Alzheimer Disease Cerebrospinal Fluid Biomarkers Predict Cognitive Decline In Healthy Elderly Over 2 Years
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer Disease Cerebrospinal Fluid Biomarkers Predict Cognitive Decline In Healthy Elderly Over 2 Years
Authors
Keywords
-
Journal
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Volume 28, Issue 3, Pages 234-238
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-03-14
DOI
10.1097/wad.0000000000000025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF biomarker changes precede symptom onset of mild cognitive impairment
- (2013) A. Moghekar et al. NEUROLOGY
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Pacientes con deterioro cognitivo leve y reducción de la proteína Aβ1-42 en LCR evolucionan rápidamente a enfermedad de Alzheimer
- (2012) J.A. Monge-Argilés et al. NEUROLOGIA
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Evidence for Ordering of Alzheimer Disease Biomarkers
- (2011) Clifford R. Jack ARCHIVES OF NEUROLOGY
- Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations
- (2011) Juan Fortea et al. Neurodegenerative Diseases
- CSF biomarkers in posterior cortical atrophy
- (2011) J. Seguin et al. NEUROLOGY
- Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42
- (2010) Jonathan M. Schott et al. ANNALS OF NEUROLOGY
- Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly
- (2009) Anne M. Fagan et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Biochemical markers in persons with preclinical familial Alzheimer disease
- (2008) J. M. Ringman et al. NEUROLOGY
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started